Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
ACC: Gamification plus financial incentives boost physical activity
Apr 11, 2024
Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events
Depression tied to higher risk of CVD events in both men and women
Mar 15, 2024
Although significant associations are seen for both, the associations are more pronounced in women.
FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Cannabis use linked to adverse cardiovascular outcomes
Feb 28, 2024
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.
Telehealth, monitoring tech, make a meaningful difference in helping seniors with hypertension: study
By
Aaron Dorman
Feb 21, 2024
Digital health interventions make a positive impact in managing hypertension among seniors, according to a study released last week.